Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026?

CME's 62% net margin and fortress balance sheet contrast sharply with Robinhood's 51% revenue growth and regulatory headwinds.

CME vs. Robinhood Markets: Which Financial Stock Is a Better Buy in 2026?

Published September 29, 2026 · Category: Finance

Overview

Choosing between established giants and disruptive newcomers is a classic investor dilemma. Is the steady reliability of CME Group (NASDAQ:CME) or the rapid expansion of Robinhood Markets (NASDAQ:HOOD) the better play?

CME operates the world's most diverse derivatives marketplace, serving institutional giants and professional traders. Robinhood focuses on democratizing finance for retail users through a sleek mobile interface. While both thrive on trading volume, they offer very different paths to growth within the broader financial landscape for everyday investors.

Details

CME Group operates a diverse marketplace for futures and options, offering clearing services across several asset classes. The exchange provides vital infrastructure for financial stocks and institutional investors seeking to hedge against price swings. According to its latest annual report filed for 2025, members accounted for nearly 85% of derivatives contract volume. The company also partners with Google Cloud to modernize its technical infrastructure and recently launched a prediction markets application through a joint venture with FanDuel.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.